AL AMYLOIDOSIS
Clinical trials for AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
New hope for rare protein disease: drug shows promise in early trial
Disease control CompletedThis study tested a drug called belantamab mafodotin in 35 people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. Participants had already tried other treatments without success. The goal was to see if the drug could reduce protein levels and impro…
Matched conditions: AL AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Protein clues may predict onset of rare genetic disease
Knowledge-focused CompletedThis study followed 37 people who carry a genetic mutation for hereditary ATTR amyloidosis but do not yet have symptoms. Over five years, researchers measured a specific misfolded protein in the blood to see if it changes when the disease starts or when treatment is needed. The g…
Matched conditions: AL AMYLOIDOSIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Heart scans may predict survival in rare amyloid disease
Knowledge-focused CompletedThis study looked at 30 people newly diagnosed with cardiac AL amyloidosis, a rare disease where abnormal proteins build up in the heart. Researchers used advanced imaging (MRI, PET, and ultrasound) along with blood tests to see which measurements best predict survival and how th…
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC